Covestor’s Cullinan Oncology CGEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$0 Sell
14
-19
-58% -$364 ﹤0.01% 2417
2026
Q2
$1K Buy
33
+23
+230% +$342 ﹤0.01% 2083
2026
Q1
$0 Sell
10
-33
-77% -$424 ﹤0.01% 2308
2025
Q4
$0 Buy
43
+33
+330% +$298 ﹤0.01% 2307
2025
Q3
$0 Hold
10
– – ﹤0.01% 2326
2025
Q2
$0 Buy
10
+5
+100% +$40 ﹤0.01% 2254
2025
Q1
$0 Hold
5
– – ﹤0.01% 2269
2024
Q4
$0 Buy
5
+1
+25% +$14 ﹤0.01% 2277
2024
Q3
$0 Sell
4
-1
-20% -$18 ﹤0.01% 2265
2024
Q2
$0 Buy
+5
New +$106 ﹤0.01% 2275
2023
Q4
– Sell
-123
Closed -$1K – 2185
2023
Q3
$1K Buy
+123
New +$1.28K ﹤0.01% 1902

Other funds holding CGEM

Covestor's CGEM Position: Q3 2026 in Review

Covestor reduced its Cullinan Oncology (CGEM) stake by 58% in Q3 2026, selling an estimated $364 and leaving 14 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2417.

Covestor first reported a position in CGEM in Q3 2023 and has held it in 11 quarters since. The position peaked at $1K in Q2 2026. 125 funds tracked by Wall St. Rank hold CGEM as of Q3 2026.

  • Covestor held 14 shares of Cullinan Oncology worth $0 as of Q3 2026.
  • Covestor sold 19 Cullinan Oncology shares in Q3 2026, an estimated $364.
  • Cullinan Oncology made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2417 holding.
  • Covestor first reported a position in Cullinan Oncology in Q3 2023 and has held it in 11 quarters since.
  • Covestor's Cullinan Oncology position peaked at $1K in Q2 2026.
  • 125 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.